Related Experiment Video
Updated: Apr 27, 2026

09:05
Flow-pattern Guided Fabrication of High-density Barcode Antibody Microarray
Published on: January 6, 2016
21.7K
Generation of miniaturized planar ecombinant antibody arrays using a microcantilever-based printer
Linn Petersson1, Nathalie Berthet Duroure, Angèle Auger
1Department of Immunotechnology, Lund University, Medicon Village, SE-22381 Lund, Sweden. CREATE Health, Lund University, Medicon Village, SE-22381 Lund, Sweden.
Nanotechnology
|June 25, 2014
Summary
A novel microspotting tool, Bioplume, enables the creation of high-density, multiplexed antibody arrays for protein expression profiling. This technology advances serum analysis with miniaturized spots and increased density, showing promise for diagnostics.
Area of Science:
- Biotechnology
- Proteomics
- Array Technology
Background:
- Miniaturized, multiplexed, and high-density antibody arrays are crucial for protein expression profiling in health and disease.
- Current methods for producing these arrays face challenges in spotter technology and density.
- Recombinant antibody arrays offer a promising platform for sensitive protein detection.
Purpose of the Study:
- To explore the utility of a novel microspotting tool, Bioplume, for producing miniaturized, multiplexed, and high-density planar recombinant antibody arrays.
- To assess the performance of these arrays for protein expression profiling using crude, directly labeled serum.
- To evaluate the reproducibility and sensitivity of the developed antibody array platform.
Main Methods:
- Utilized Bioplume, a microspotting tool with an array of silicon cantilevers and integrated microfluidic channels.
- Produced miniaturized (Ø 10 μm) spot features with high density (>250,000 spots cm(-2)).
- Interfaced the antibody arrays with a fluorescent-based readout system for protein detection.
Main Results:
- Successfully produced 16-plex recombinant antibody arrays with miniaturized spot features (78.5 μm², Ø 10 μm).
- Achieved a 7-125-fold increase in spot density compared to existing technologies (250,000 spots cm⁻²).
- Demonstrated adequate spot-to-spot reproducibility and assay sensitivity in the picomolar (pM) range.
Conclusions:
- The Bioplume microspotting tool is effective for generating high-density, miniaturized recombinant antibody arrays.
- The developed platform shows feasibility for serum protein profiling, offering enhanced density and sensitivity.
- This technology holds potential for advancing protein expression analysis in clinical diagnostics.

